About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MoleGazer Development Feasibility Study | Clinical Trials | Clareo Health

Active Not RecruitingNA

MoleGazer Development Feasibility Study

MoleGazer: A Feasibility Study for Early Detection of Melanoma

NCT05015816•Oxford University Hospitals NHS Trust

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Melanoma (Skin)Moles Multiple Benign

Interventions

Total body photography

Locations

1

United Kingdom

Locations (1)

Churchill Hospital

Headington, Oxford, United Kingdom

Key Dates

Start Date

September 13, 2021

Primary Completion Date

February 28, 2024

Completion Date

February 28, 2026

Last Updated

July 31, 2025

Related Studies

RECRUITINGPhase 1/2

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

NCT06956690

Melanoma (Skin)Non Small Cell Lung Cancer+1 more

Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors

NCT05649683

Melanoma (Skin)

Active Not RecruitingPhase 3

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

NCT00003641

Melanoma (Skin)

Active Not RecruitingEARLY Phase 1

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

NCT03543969

Melanoma (Skin)Skin Cancer+2 more

Active Not RecruitingPhase 2

SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

NCT04079166

Malignant MelanomaMelanoma (Skin)+2 more

Active Not RecruitingPhase 1

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

NCT05492682

Melanoma (Skin)Triple-Negative Breast Cancer+6 more

View all related studies

Sponsors

Lead Sponsor

Oxford University Hospitals NHS Trust

Collaborators

University of Southampton

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 31, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions